Novartis (US Pharmaceuticals)
(https://pharma.us.novartis.com) 📸 Data Snapshot: May 28, 2026Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
The review_count and proof_links_count are both 0 across the available data, indicating a total lack of trust signals. There are no performance claims to verify, but the absence of external validation paths or regulatory links creates a vacuum of proof. The site fails to provide even the most basic trust theatre, such as logos or partner mentions, as it is non-functional.
The proof density is non-existent, as evidenced by a proof_links_count of 0 and a review_count of 0. There are no links to peer-reviewed studies, clinical trials, or regulatory clearances. The only verifiable entity mentioned is ‘Acquia Inc.,’ which has no relationship to the medical claims or regulatory expectations associated with the domain.
Trust & Proof is read by weighing trust language against real verification. Below is the page-by-page tally of review mentions and external proof links, then the schema markup that may (or may not) declare verifiable ratings and identity proof.
🛡️ Trust Signals — reviews, proof links, trust-theatre check
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: declared ratings, reviews & identity proof
This page presents a snapshot of public data from Novartis (US Pharmaceuticals), captured on May 28, 2026, to show how machine logic reads Trust & Proof signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Novartis (US Pharmaceuticals): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://pharma.us.novartis.com to view the most current version of its content and see directly what this company is about and what it offers.